Medtronic has recalled nearly 97,000 advanced InSync III pacemakers for treating heart failure, saying the globally distributed devices may have batteries that put out less power than they should.
In letters published over the extended holiday break, regulators in the U.S. and Germany said at least 22,000 of the battery-powered InSync III CRT implantable pacemakers made by Medtronic remain inside patients, and could fail earlier than expected. Medtronic’s cardiac devices division in suburban Minneapolis is handling the worldwide recall.
